Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Lymphoma, Mantle-Cell
×
ibritumomab tiuxetan
×
Clear all
Filters
3
NCT01448928
2021-10-01
ZEVALIN-DUI
Spectrum Pharmaceuticals, Inc
Completed
400 enrolled
NCT00505232
2012-01-02
LCM-04-02
CABYC
Phase 2
Completed
30 enrolled
NCT01479387
2011-11-24
ZEVALIN-SDUI
Bayer
Completed
72 enrolled